A benefit-cost analysis quantifying the broader socioeconomic value of adult respiratory vaccination programs in Japan [0.03%]
日本成人呼吸道疫苗接种项目的经济学分析：量化更广泛的社会经济价值
Claud Theakston,Matthew Napier,Simon Brassel et al.
Claud Theakston et al.
Background: Respiratory infections like pneumococcal disease (PD), respiratory syncytial virus (RSV), influenza (Flu), and COVID-19 significantly impact Japan's aging population, imposing substantial health and economic b...
Real-world effectiveness of varicella vaccination in Guangzhou, China, 2017-2022: a matched case-control analysis [0.03%]
中国广州市2017-2022年水痘疫苗的实证效果：病例对照匹配分析
Junxi Li,Yong Huang,Siyu Chen et al.
Junxi Li et al.
Background: China has yet to implement a nationwide two-dose vaccination strategy. This study assesses the real-world effectiveness of varicella vaccination in Guangzhou, where the policy recommends voluntary, self-funded...
Immunogenicity and safety of meningococcal vaccines, MenACWY-CRM and 4CMenB, in groups at increased risk for meningococcal disease [0.03%]
针对流行性脑膜炎高危人群的脑膜炎奈瑟菌疫苗MenACWY-CRM和4CMenB的免疫原性和安全性研究
Shravani Bobde,Chiranjiwi Bhusal,Catherine A Cosgrove et al.
Shravani Bobde et al.
Introduction: Individuals with immunocompromising conditions (e.g. asplenia, complement deficiency, HIV infection) or with high exposure to Neisseria meningitidis (e.g. laboratory workers, those in outbreak settings) have...
Public health impact of nirsevimab against acute lower respiratory infections associated with respiratory syncytial virus among Chinese infants: a modelling study [0.03%]
针对中国婴儿呼吸道合胞病毒相关急性下呼吸道感染的尼塞维单抗公共健康影响预测：建模研究
Xiaozhen Lai,Yidi Ma,Weishun Zou et al.
Xiaozhen Lai et al.
Background: Respiratory syncytial virus (RSV) causes substantial acute lower respiratory infections (ALRI), particularly during infants' first RSV season. This study evaluated the impact of a new long-acting monoclonal an...
Relationship between parental vaccine literacy and their willingness to vaccinate children against influenza in china [0.03%]
中国家长的疫苗素养及其儿童流感疫苗接种意愿之间的关系研究
Zhuoran Huang,Ziwen Song,Minjuan Shi et al.
Zhuoran Huang et al.
Background: Influenza poses a significant global public health burden, particularly among pediatric populations. However, the coverage of influenza vaccination among Chinese children remains inadequate. ...
Changes in serotype distribution and antimicrobial nonsusceptibility of streptococcus pneumoniae among hospitalized children: Shenzhen, China, 2009-2019 [0.03%]
2009-2019年我国深圳市住院儿童肺炎链球菌血清型分布及对临床常用抗菌药物耐药性的变迁监测
Feiling Wang,Xiaojing Zeng,Qianqian Du et al.
Feiling Wang et al.
Background: This study assessed changes in Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility among hospitalized children with pneumonia in Shenzhen, China, from 2009 to 2019, under low pne...
Rebuilding vaccine confidence in Latin America and the Caribbean: strategies for the Post-pandemic Era [0.03%]
拉美和加勒比地区重建疫苗信任： pandemic 之后的策略
Roberto Debbag,Julián Gallo,María L Ávila-Agüero et al.
Roberto Debbag et al.
Introduction: Vaccine hesitancy in Latin America and the Caribbean (LAC) has a complex nature. It is shaped by socio-political, cultural, economic factors, and an influence of the COVID-19 pandemic on increasing hesitancy...
Advancing respiratory syncytial virus (RSV) prevention in Latin America: updated recommendations from the Pediatric Infectious Diseases society of Latin America (SLIPE) expert group on RSV prevention [0.03%]
拉丁美洲儿科传染病协会(SLIPe)预防RSV专家组关于改善呼吸合胞病毒(RSV)预防的最新建议
María L Ávila-Agüero,Roberto Debbag,Helena Brenes-Chacón et al.
María L Ávila-Agüero et al.
Potential public health impact of the adjuvanted RSVPreF3 vaccine in adults aged 60 years and older: results from a modeling study in India and Southeast Asia [0.03%]
一项关于印度和东南亚60岁及以上老年人中RSVPreF3佐剂疫苗潜在公共卫生成本效益的模拟研究结果
Ru Han,Ja Gomez,Cn Quy et al.
Ru Han et al.
Background: Respiratory syncytial virus (RSV) can cause acute respiratory infection (ARI) and severe symptoms in adults ≥60 years. The adjuvanted RSV prefusion F protein vaccine (adjuvanted RSVPreF3) offers protection to...
Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus [0.03%]
打破常规：针对水痘带状疱疹病毒生命周期的疫苗策略的思考
Giacomo Casabona,Paolo Bonanni,Giovanni Gabutti et al.
Giacomo Casabona et al.
Introduction: Varicella-zoster virus (VZV) is a highly contagious virus that manifests as varicella (chickenpox) as primary infection and reactivates as herpes zoster (HZ, shingles), with the potential for severe complica...